AudioAbstracts-logo

AudioAbstracts

ReachMD

Welcome to On the Frontlines of Multiple Sclerosis, a ReachMD series with the latest education and information on diagnostic and prognostic advancements and treatment options for patients with Multiple Sclerosis.

Welcome to On the Frontlines of Multiple Sclerosis, a ReachMD series with the latest education and information on diagnostic and prognostic advancements and treatment options for patients with Multiple Sclerosis.
More Information

Location:

United States

Networks:

ReachMD

Description:

Welcome to On the Frontlines of Multiple Sclerosis, a ReachMD series with the latest education and information on diagnostic and prognostic advancements and treatment options for patients with Multiple Sclerosis.

Language:

English


Episodes

Is There a Link Between IUD Use & Breast Cancer Risk?

4/27/2018
More
This episode of Audio Abstracts reviews two studies conducted in Finland that investigated the link between premenopausal use of hormonal intrauterine treatment for menorrhagia and breast cancer incidence rates. The first study, Cancer Risk in Women Using the Levonorgestrel-Releasing Intrauterine System in Finland, examined the incidence rates of several common cancers among intrauterine treatment users. The authors found that the risk of breast cancer increased within this patient...

Duration:00:05:00

Cervical Cancer Screening: The Latest Research on the Impact of Different Cytology Methods

1/16/2018
More
Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates. Rozemeijer K, Penning C, Siebers AG, Naber SK, Matthijsse SM, van Ballegooijen M, van Kemenade FJ, de Kok IM. Cancer Causes Control. 2016 Jan;27(1):15-25.doi: 10.1007/s10552-015-0678-1. Epub 2015 Oct 12. Background Information: In the previous audio abstract summarizing the results from these researchers from the Erasmus Medical Center in the...

Duration:00:03:29

Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance

1/2/2018
More
Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance. Liefferinckx C1, Minsart C, Toubeau JF, Cremer A, Amininejad L, Quertinmont E, Devière J, Gils A, van Gossum A, Franchimont D. BACKGROUND: Infliximab (IFX) is indicated for the treatment of inflammatory bowel diseases (IBD). Nevertheless, loss of response (LOR) to IFX is reported in up to 10% to 30% of patients within the first year of treatment. Our objective was to evaluate the impact of the...

Duration:00:04:29

Individual detection of 14 high-risk HPV genotypes by the PapType test for the prediction of high-grade cervical lesions

7/29/2016
More
Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions. Cuzick J, Ho L, Terry G, Kleeman M, Giddings M, Austin J, Cadman L, Ashdown-Barr L, Costa MJ, Szarewski A. J Clin Virol. 2014 May;60(1):44-9. doi: 10.1016/j.jcv.2014.02.002. Epub 2014 Feb 14. Abstract BACKGROUND: HR HPV genotypes when assayed collectively, achieve high sensitivity but low specificity for the prediction of CIN2+. Knowledge of the...

Duration:00:05:30